PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Unit of Pharmacology, Department of Pharmacy and Drug Sciences, University of Bari Aldo Moro, Bari, Italy.\', \'Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands; Duchenne Parent Project, the Netherlands.\', \'Duchenne Parent Project, the Netherlands; World Duchenne Organisation (UPPMD), the Netherlands.\', \'Unit of Pharmacology, Department of Pharmacy and Drug Sciences, University of Bari Aldo Moro, Bari, Italy. Electronic address: annamaria.deluca@uniba.it.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1043-6618(20)31225-110.1016/j.phrs.2020.104917
?:doi
?:hasPublicationType
?:journal
  • Pharmacological research
is ?:pmid of
?:pmid
?:pmid
  • 32485610
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.811
?:rankingScore_hIndex
  • 112
is ?:relation_isRelatedTo_publication of
?:title
  • Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all